1. Effects of USPSTF guidelines on patterns of screening and treatment outcomes for prostate cancer
    Vindya Gunawardena, 2014, World Journal of Translational Medicine CrossRef
  2. Evaluation of 12-Lipoxygenase (12-LOX) and Plasminogen Activator Inhibitor 1 (PAI-1) as Prognostic Markers in Prostate Cancer
    Tomasz Gondek et al, 2014, BioMed Research International CrossRef
  3. Molecular analyses of prostate tumors for diagnosis of malignancy on fine-needle aspiration biopsies
    Menglin Shan et al, 2017, Oncotarget CrossRef
  4. Histologically benign PI‐RADS 4 and 5 lesions contain cancer‐associated epigenetic alterations
    Ceren Şeref et al, 2022, The Prostate CrossRef
  5. Exploring glyoxalase 1 expression in prostate cancer tissues: Targeting the enzyme by ethyl pyruvate defangs some malignancy‐associated properties
    Martin Baunacke et al, 2014, The Prostate CrossRef
  6. Searching for the answer to cancer: New perspective may help to resolve an ageless conundrum
    Richard A. Watson, 2013, Urologic Oncology: Seminars and Original Investigations CrossRef
  7. Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges
    Mintu Pal et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  8. Next-Generation Molecular Markers: Challenges, Applications and Future Perspectives
    Mukesh Verma et al, 2019, Genomics and Clinical Diagnostics CrossRef
  9. RETRACTED ARTICLE: ChIP-seq analysis of androgen receptor in LNCaP cell line
    Sifeng Tao et al, 2014, Molecular Biology Reports CrossRef
  10. Molecular Signatures in Urologic Tumors
    Spencer Larkin et al, 2013, International Journal of Molecular Sciences CrossRef
  11. Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers
    Haitham A Badr et al, 2014, Expert Review of Proteomics CrossRef
  12. Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer
    Pedro Costa-Pinheiro et al, 2014, Expert Review of Anticancer Therapy CrossRef
  13. Evaluation of prediction models for the staging of prostate cancer
    Susie Boyce et al, 2013, BMC Medical Informatics and Decision Making CrossRef
  14. Inhibitors targeting epigenetic modifications in cancer
    Vinit Singh Baghel et al, 2023, Transcription and Translation in Health and Disease CrossRef
  15. The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer
    Claire Tonry et al, 2016, Diagnostics CrossRef
  16. Timelines of Prostate Cancer Biomarkers
    Gabriela Jurca et al, 2018, Social Network Based Big Data Analysis and Applications CrossRef
  17. Synergy between molecular biology and imaging science toward mechanism-based biomarkers associated with prostate cancer
    Belinda Seto, 2012, Journal of Biomedical Science and Engineering CrossRef
  18. Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro
    ZHENG-HUA HUANG et al, 2015, Molecular Medicine Reports CrossRef
  19. The αvβ6 Integrin Is Transferred Intercellularly via Exosomes
    Carmine Fedele et al, 2015, Journal of Biological Chemistry CrossRef
  20. Multiplexed Prostate Cancer Companion Diagnostic Devices
    Josephine Aidoo-Brown et al, 2021, Sensors CrossRef
  21. Bayesian adaptive design of early-phase clinical trials for precision medicine based on cancer biomarkers
    Shinjo Yada, 2022, The International Journal of Biostatistics CrossRef
  22. Metabolomics and Proteomics in Prostate Cancer Research: Overview, Analytical Techniques, Data Analysis, and Recent Clinical Applications
    Fatima M. Al-Daffaie et al, 2024, International Journal of Molecular Sciences CrossRef
  23. Diagnosis and Treatment of Cancer—Where We are and Where We have to Go!
    Rajiv Lochan Gaur et al, 2014, Advanced Healthcare Materials CrossRef
  24. Overexpression and purification of folded domain of prostate cancer related proteins MSMB and PSA
    Mohini Tiwary et al, 2016, Molecular Biology Reports CrossRef
  25. Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infection
    S. Tsiomita et al, 2018, Infection, Genetics and Evolution CrossRef
  26. New Developments in the Use of Biomarkers in Translational Medicine
    Benedikte Serruys et al, 2016, Translational Medicine CrossRef
  27. An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer
    Helen Saxby et al, 2020, Diagnostics CrossRef
  28. Diagnostic and Prognostic Epigenetic Biomarkers in Cancer
    Pedro Costa-Pinheiro et al, 2015, Epigenomics CrossRef
  29. Protein biomarker detection in prostate cancer: A comprehensive review of electrochemical biosensors
    Hashmatullah Nasimi et al, 2023, Sensors and Actuators Reports CrossRef
  30. Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management
    Claire Tonry et al, 2020, Clinical Proteomics CrossRef